BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31671431)

  • 1. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
    Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
    Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial central precocious puberty: two novel MKRN3 mutations.
    Varimo T; Iivonen AP; Känsäkoski J; Wehkalampi K; Hero M; Vaaralahti K; Miettinen PJ; Niedziela M; Raivio T
    Pediatr Res; 2021 Aug; 90(2):431-435. PubMed ID: 33214675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MKRN3 Levels in Girls with Central Precocious Puberty during GnRHa Treatment: A Longitudinal Study.
    Grandone A; Cirillo G; Sasso M; Tornese G; Luongo C; Festa A; Marzuillo P; Miraglia Del Giudice E
    Horm Res Paediatr; 2018; 90(3):190-195. PubMed ID: 30269125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-Phenotype Correlations in Central Precocious Puberty Caused by MKRN3 Mutations.
    Seraphim CE; Canton APM; Montenegro L; Piovesan MR; Macedo DB; Cunha M; Guimaraes A; Ramos CO; Benedetti AFF; de Castro Leal A; Gagliardi PC; Antonini SR; Gryngarten M; Arcari AJ; Abreu AP; Kaiser UB; Soriano-Guillén L; Escribano-Muñoz A; Corripio R; Labarta JI; Travieso-Suárez L; Ortiz-Cabrera NV; Argente J; Mendonca BB; Brito VN; Latronico AC
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1041-1050. PubMed ID: 33383582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Frequency of MKRN3 Mutations in Male Central Precocious Puberty Previously Classified as Idiopathic.
    Bessa DS; Macedo DB; Brito VN; França MM; Montenegro LR; Cunha-Silva M; Silveira LG; Hummel T; Bergadá I; Braslavsky D; Abreu AP; Dauber A; Mendonca BB; Kaiser UB; Latronico AC
    Neuroendocrinology; 2017; 105(1):17-25. PubMed ID: 27225315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometric, metabolic, and reproductive outcomes of patients with central precocious puberty treated with leuprorelin acetate 3-month depot (11.25 mg).
    Ramos CO; Canton APM; Seraphim CE; Faria AG; Tinano FR; Mendonca BB; Latronico AC; Brito VN
    J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1371-1377. PubMed ID: 34298591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Genetic Characterization of Familial Central Precocious Puberty.
    Tinano FR; Canton APM; Montenegro LR; de Castro Leal A; Faria AG; Seraphim CE; Brauner R; Jorge AA; Mendonca BB; Argente J; Brito VN; Latronico AC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1758-1767. PubMed ID: 36611250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel heterozygous MKRN3 nonsense mutation in a Chinese girl with idiopathic central precocious puberty: A case report.
    Liu M; Fan L; Gong CX
    Medicine (Baltimore); 2020 Sep; 99(38):e22295. PubMed ID: 32957387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
    Tao Y; Si C; Li H; Han J; Hou H; Yang M
    Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
    Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Makorin ring finger protein 3 values for predicting Central precocious puberty in girls.
    Jeong HR; Lee HJ; Shim YS; Kang MJ; Yang S; Hwang IT
    Gynecol Endocrinol; 2019 Aug; 35(8):732-736. PubMed ID: 30806524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone analogs treatment in girls with central precocious puberty and early fast puberty.
    Lerman L; Yackobovitch-Gavan M; Phillip M; Shalitin S
    Pediatr Res; 2024 Mar; 95(4):1051-1059. PubMed ID: 37935883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.
    Bereket A
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):33-48. PubMed ID: 29280737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional study of a novel MKRN3 missense mutation associated with familial central precocious puberty.
    Chen Z; You Q; Wang J; Dong Z; Wang W; Yang Y; Ma X; Li C; Lu W
    Am J Med Genet A; 2024 Apr; 194(4):e63460. PubMed ID: 38054352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Makorin Ring Finger Protein 3 Levels Between Obese and Normal Weight Patients with Central Precocious Puberty.
    Eren SE; Şimşek E
    J Clin Res Pediatr Endocrinol; 2023 May; 15(2):182-189. PubMed ID: 36728292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls.
    Fu J; Zhang J; Chen R; Ma X; Wang C; Chen L; Liang Y; Luo X; Yang Y; Xiong F; Su Z; Wu J; Yao H; Xu J; Wu D; Ni Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31702013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades.
    Lazar L; Lebenthal Y; Yackobovitch-Gavan M; Shalitin S; de Vries L; Phillip M; Meyerovitch J
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1445-51. PubMed ID: 25650898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.